POSB22 Indirect Treatment Comparisons of Empagliflozin Versus Sacubitril/Valsartan for the Treatment of Patients with Heart Failure with Reduced Ejection Fraction (HFREF)
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.132
https://www.valueinhealthjournal.com/article/S1098-3015(21)01927-6/fulltext
Title :
POSB22 Indirect Treatment Comparisons of Empagliflozin Versus Sacubitril/Valsartan for the Treatment of Patients with Heart Failure with Reduced Ejection Fraction (HFREF)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01927-6&doi=10.1016/j.jval.2021.11.132
First page :
Section Title :
Open access? :
No
Section Order :
10900